CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?
Autoimmune rheumatic diseases (ARDs), such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis, involve dysregulated immune responses causing chronic inflammation and tissue damage. Despite advancements in clinical management, many patients do not respond to current treatme...
Saved in:
Main Authors: | Carlos Rangel-Peláez, Laura Martínez-Gutiérrez, María Tristán-Manzano, José Luis Callejas, Norberto Ortego-Centeno, Francisco Martín, Javier Martín |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1502712/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases
by: Winston Gilcrease, et al.
Published: (2024-11-01) -
The advent of chimeric antigen receptor T Cell therapy in recalibrating immune balance for rheumatic autoimmune disease treatment
by: Qianyu Guo, et al.
Published: (2024-12-01) -
Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders
by: Fancheng Liu, et al.
Published: (2025-02-01) -
Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases
by: Michaela Fehringer, et al.
Published: (2025-06-01) -
The Role of Prolactin as a Disease Activity Indicator in Some Rheumatic Diseases
by: Mohamed Ismail Abdelkarem, et al.
Published: (2025-07-01)